These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

444 related articles for article (PubMed ID: 16936272)

  • 1. B and T lymphocytes are the primary sources of RANKL in the bone resorptive lesion of periodontal disease.
    Kawai T; Matsuyama T; Hosokawa Y; Makihira S; Seki M; Karimbux NY; Goncalves RB; Valverde P; Dibart S; Li YP; Miranda LA; Ernst CW; Izumi Y; Taubman MA
    Am J Pathol; 2006 Sep; 169(3):987-98. PubMed ID: 16936272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune response: the key to bone resorption in periodontal disease.
    Taubman MA; Valverde P; Han X; Kawai T
    J Periodontol; 2005 Nov; 76(11 Suppl):2033-41. PubMed ID: 16277573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble RANKL Cleaved from Activated Lymphocytes by TNF-α-Converting Enzyme Contributes to Osteoclastogenesis in Periodontitis.
    Kanzaki H; Makihira S; Suzuki M; Ishii T; Movila A; Hirschfeld J; Mawardi H; Lin X; Han X; Taubman MA; Kawai T
    J Immunol; 2016 Nov; 197(10):3871-3883. PubMed ID: 27815441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LPS-stimulated human gingival fibroblasts inhibit the differentiation of monocytes into osteoclasts through the production of osteoprotegerin.
    Nagasawa T; Kobayashi H; Kiji M; Aramaki M; Mahanonda R; Kojima T; Murakami Y; Saito M; Morotome Y; Ishikawa I
    Clin Exp Immunol; 2002 Nov; 130(2):338-44. PubMed ID: 12390325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective blockade of voltage-gated potassium channels reduces inflammatory bone resorption in experimental periodontal disease.
    Valverde P; Kawai T; Taubman MA
    J Bone Miner Res; 2004 Jan; 19(1):155-64. PubMed ID: 14753747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bacterial-responsive B lymphocytes induce periodontal bone resorption.
    Han X; Kawai T; Eastcott JW; Taubman MA
    J Immunol; 2006 Jan; 176(1):625-31. PubMed ID: 16365458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activated human T cells directly induce osteoclastogenesis from human monocytes: possible role of T cells in bone destruction in rheumatoid arthritis patients.
    Kotake S; Udagawa N; Hakoda M; Mogi M; Yano K; Tsuda E; Takahashi K; Furuya T; Ishiyama S; Kim KJ; Saito S; Nishikawa T; Takahashi N; Togari A; Tomatsu T; Suda T; Kamatani N
    Arthritis Rheum; 2001 May; 44(5):1003-12. PubMed ID: 11352231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein kinase-A-dependent osteoprotegerin production on interleukin-1 stimulation in human gingival fibroblasts is distinct from periodontal ligament fibroblasts.
    Hormdee D; Nagasawa T; Kiji M; Yashiro R; Kobayashi H; Koshy G; Noguchi K; Nitta H; Ishikawa I
    Clin Exp Immunol; 2005 Dec; 142(3):490-7. PubMed ID: 16297161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diminished forkhead box P3/CD25 double-positive T regulatory cells are associated with the increased nuclear factor-kappaB ligand (RANKL+) T cells in bone resorption lesion of periodontal disease.
    Ernst CW; Lee JE; Nakanishi T; Karimbux NY; Rezende TM; Stashenko P; Seki M; Taubman MA; Kawai T
    Clin Exp Immunol; 2007 May; 148(2):271-80. PubMed ID: 17355249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of the osteoprotegerin/receptor activator of nuclear factor-kappa B ligand system in gingival crevicular fluid and tissue of patients with chronic periodontitis.
    Lu HK; Chen YL; Chang HC; Li CL; Kuo MY
    J Periodontal Res; 2006 Aug; 41(4):354-60. PubMed ID: 16827732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional human T-cell immunity and osteoprotegerin ligand control alveolar bone destruction in periodontal infection.
    Teng YT; Nguyen H; Gao X; Kong YY; Gorczynski RM; Singh B; Ellen RP; Penninger JM
    J Clin Invest; 2000 Sep; 106(6):R59-67. PubMed ID: 10995794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osteoclastogenesis is enhanced by activated B cells but suppressed by activated CD8(+) T cells.
    Choi Y; Woo KM; Ko SH; Lee YJ; Park SJ; Kim HM; Kwon BS
    Eur J Immunol; 2001 Jul; 31(7):2179-88. PubMed ID: 11449372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cytolethal distending toxin induces receptor activator of NF-kappaB ligand expression in human gingival fibroblasts and periodontal ligament cells.
    Belibasakis GN; Johansson A; Wang Y; Chen C; Kalfas S; Lerner UH
    Infect Immun; 2005 Jan; 73(1):342-51. PubMed ID: 15618171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokine pattern determines the progression of experimental periodontal disease induced by Actinobacillus actinomycetemcomitans through the modulation of MMPs, RANKL, and their physiological inhibitors.
    Garlet GP; Cardoso CR; Silva TA; Ferreira BR; Avila-Campos MJ; Cunha FQ; Silva JS
    Oral Microbiol Immunol; 2006 Feb; 21(1):12-20. PubMed ID: 16390336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential expression of RANKL and osteoprotegerin in gingival crevicular fluid of patients with periodontitis.
    Mogi M; Otogoto J; Ota N; Togari A
    J Dent Res; 2004 Feb; 83(2):166-9. PubMed ID: 14742657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin (IL) 18 stimulates osteoclast formation through synovial T cells in rheumatoid arthritis: comparison with IL1 beta and tumour necrosis factor alpha.
    Dai SM; Nishioka K; Yudoh K
    Ann Rheum Dis; 2004 Nov; 63(11):1379-86. PubMed ID: 15479886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In situ expression of RANKL, RANK, osteoprotegerin and cytokines in osteoclasts of rat periodontal tissue.
    Ogasawara T; Yoshimine Y; Kiyoshima T; Kobayashi I; Matsuo K; Akamine A; Sakai H
    J Periodontal Res; 2004 Feb; 39(1):42-9. PubMed ID: 14687227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-gamma.
    Takayanagi H; Ogasawara K; Hida S; Chiba T; Murata S; Sato K; Takaoka A; Yokochi T; Oda H; Tanaka K; Nakamura K; Taniguchi T
    Nature; 2000 Nov; 408(6812):600-5. PubMed ID: 11117749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-7 induces bone loss in vivo by induction of receptor activator of nuclear factor kappa B ligand and tumor necrosis factor alpha from T cells.
    Toraldo G; Roggia C; Qian WP; Pacifici R; Weitzmann MN
    Proc Natl Acad Sci U S A; 2003 Jan; 100(1):125-30. PubMed ID: 12490655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Joint erosion in rheumatoid arthritis: interactions between tumour necrosis factor alpha, interleukin 1, and receptor activator of nuclear factor kappaB ligand (RANKL) regulate osteoclasts.
    O' Gradaigh D; Ireland D; Bord S; Compston JE
    Ann Rheum Dis; 2004 Apr; 63(4):354-9. PubMed ID: 15020327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.